Trials / Completed
CompletedNCT04572399
UVA Light Device to Treat COVID-19
Respiratory Application of a Novel Ultraviolet Light Delivery Device for Patients Infected With COVID-19: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Cedars-Sinai Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This pilot study will assess the safety and effectiveness of UV light treatment in hospitalized patients with COVID-19.
Detailed description
This is a single center, open label, pilot study. 5 adult patients, aged over 18, who are confirmed positive with SARS-CoV-2 and are newly intubed, will receive UV light treatment to reduce SARS-CoV-2 viral load.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | UV Light Treatment | UV light therapy administered while patient is mechanically ventilated |
Timeline
- Start date
- 2020-10-30
- Primary completion
- 2020-12-28
- Completion
- 2020-12-28
- First posted
- 2020-10-01
- Last updated
- 2025-01-09
- Results posted
- 2022-01-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04572399. Inclusion in this directory is not an endorsement.